Landscapes / Companies

Biogen not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
6 approved
3 in Phase 3
Next date
Felzartamab, Phase 3 trial completes
Drugs
14
in active trials · 57 in all
Trials
30 active
186 since 2021

Drugs14

DrugHow it worksPartnerStageNext dateDetails
Interferon beta
Approved 20 May 2027Phase 3 trial completes
Antisense oligonucleotide
Approved 26 May 2027Phase 4 trial completes
Survival motor neuron-2-directed RNA Interaction; antisense oligonucleotide
Approved 24 Sep 2027Phase 3 trial completes
—
Approved 16 Nov 2027Phase 3 trial completes
—
Approved 28 Jul 2034Phase 3 trial completes
—
Approved 28 Jul 2034Phase 3 trial completes
Monoclonal antibody
Phase 3 1 Dec 2026soonPhase 3 trial completes
—
Phase 3 23 Jun 2028Phase 3 trial completes
Monoclonal antibody
Phase 3 26 Jun 2029Phase 3 trial completes
—
Phase 1/2 23 Jan 2034Phase 1/2 trial completes
—
Phase 2 —
—
Phase 1 2 Feb 2027Phase 1 trial completes
—
Phase 1 19 Jun 2028Phase 1 trial completes
—
Phase 1 —

About

No active trial
43 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Biogen

Following is part of Solo: you see every change to Biogen the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in